STERIS plc Share Price

Equities

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 31/05/2024 BST 5-day change 1st Jan Change
222.9 USD -0.15% Intraday chart for STERIS plc -2.74% +1.38%
Sales 2025 * 5.53B 434B Sales 2026 * 5.82B 457B Capitalization 22.04B 1,730B
Net income 2025 * 659M 51.73B Net income 2026 * 765M 60.05B EV / Sales 2025 * 4.43 x
Net Debt 2025 * 2.46B 193B Net Debt 2026 * 1.93B 151B EV / Sales 2026 * 4.12 x
P/E ratio 2025 *
32.7 x
P/E ratio 2026 *
28.5 x
Employees 18,000
Yield 2025 *
1%
Yield 2026 *
1.09%
Free-Float 99.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week-2.74%
1 month+8.70%
3 months-4.25%
6 months+9.52%
Current year+1.38%
More quotes
1 week
221.30
Extreme 221.3
229.28
1 month
205.95
Extreme 205.95
239.19
Current year
197.82
Extreme 197.82
239.19
1 year
195.47
Extreme 195.47
254.00
3 years
159.21
Extreme 159.21
255.93
5 years
105.69
Extreme 105.69
255.93
10 years
49.78
Extreme 49.78
255.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 31/07/18
Director of Finance/CFO 56 31/01/14
Investor Relations Contact - 30/04/04
Members of the board TitleAgeSince
Director/Board Member 74 31/03/08
Director/Board Member 74 30/09/03
Director/Board Member 58 27/07/20
More insiders
Date Price Change Volume
31/05/24 222.9 -0.15% 934,289
30/05/24 223.2 -0.09% 404,311
29/05/24 223.4 +0.01% 414,181
28/05/24 223.4 -2.52% 457,429
24/05/24 229.2 +1.04% 510,545

Delayed Quote Nyse, May 31, 2024 at 09:00 pm

More quotes
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
222.9 USD
Average target price
243.5 USD
Spread / Average Target
+9.25%
Consensus